# Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease

> **NCT05362786** · PHASE1 · COMPLETED · sponsor: **LaTonya J. Hickson** · enrollment: 14 (actual)

## Conditions studied

- Chronic Kidney Diseases

## Interventions

- **DRUG:** Allogeneic adipose-derived mesenchymal stem cells (MSC)
- **DRUG:** Allogeneic adipose-derived mesenchymal stem cells (MSC)

## Key facts

- **NCT ID:** NCT05362786
- **Lead sponsor:** LaTonya J. Hickson
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-01
- **Primary completion:** 2024-07-24
- **Final completion:** 2024-07-24
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2024-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05362786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05362786, "Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05362786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*